Xvivo Perfusion AB (publ)
XVIPY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $172,182 | $91,820 | $22,314 | $6,665 |
| Dep. & Amort. | $67,424 | $30,863 | $42,167 | $32,257 |
| Deferred Tax | $0 | $0 | -$6,687 | -$2,602 |
| Stock-Based Comp. | $6,570 | $2,302 | $0 | $2,602 |
| Change in WC | -$79,115 | -$39,224 | -$22,167 | -$23,218 |
| Other Non-Cash | -$55,771 | -$39,474 | -$14,458 | -$27,763 |
| Operating Cash Flow | $111,290 | $46,287 | $27,856 | -$12,059 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$70,731 | -$43,015 | -$130,946 | -$94,074 |
| Net Acquisitions | -$50,459 | -$17,680 | -$67,447 | -$93,228 |
| Inv. Purchases | $0 | $0 | $179,439 | -$401 |
| Inv. Sales/Matur. | $0 | $0 | $769 | $83,880 |
| Other Inv. Act. | -$122,624 | -$100,924 | -$179,439 | -$83,880 |
| Investing Cash Flow | -$243,814 | -$161,619 | -$197,624 | -$187,703 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$10,902 | $0 | $0 | -$5,940 |
| Stock Issued | $0 | $429,250 | $815 | $245,353 |
| Stock Repurch. | $0 | $0 | -$368 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$10,703 | -$7,289 | -$4,802 |
| Financing Cash Flow | -$10,902 | $418,547 | -$6,842 | $234,611 |
| Forex Effect | $12,859 | -$3,672 | $24,459 | $9,611 |
| Net Chg. in Cash | -$130,567 | $299,543 | -$152,151 | $44,460 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $546,088 | $246,545 | $398,696 | $354,236 |
| End Cash | $415,521 | $546,088 | $246,545 | $398,696 |
| Free Cash Flow | $40,559 | -$97,649 | -$103,090 | -$106,133 |